ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.40
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,868.95
      -0.06%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Marinus Pharmaceuticals Inc (MRNS)

      7. Marinus Pharmaceuticals Inc (MRNS) Financials

      Marinus Pharmaceuticals Inc

      Marinus Pharmaceuticals Inc (MRNS)

      -3x Mrna
      1.43
      0.02
      (1.42%)
      Closed July 26 4:00PM
      Delayed by 15 minutes
      1.45
      0.02
      (1.40%)
      After Hours: 7:25PM
      Delayed by 15 minutes

      Marinus Pharmaceuticals Inc Financial Summary

      The current MRNS market cap is 79.65M. The company's latest EPS is USD -2.5741 and P/E is -0.56.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 10.38M6.08M7.34M7.19M7.68M
      Operating Income -32.96M-31.44M-31.65M-35.44M-35.82M
      Net Income -34.73M-31.93M-32.97M-41.77M-38.67M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 01.72M15.35M25.48M30.99M
      Operating Income -54.42M-67.94M-96.93M-112.79M-131.49M
      Net Income -54.12M-67.48M-98.78M-19.82M-141.41M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 226.82M201.2M200.81M170.91M137.35M
      Total Liabilities 141.73M143.86M146.27M154.14M153.78M
      Total Equity 85.09M57.34M54.54M16.77M-16.43M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 98.84M150.46M136.84M259.52M170.91M
      Total Liabilities 11.07M13.26M83.35M143.52M154.14M
      Total Equity 59.57M137.2M53.49M116M16.77M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -41.48M-65.84M-91.01M-118M-37.46M
      Investing -52M-46.99M-35.07M-28.61M20.89M
      Financing -174k63k25.97M26.63M257k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -48.63M-60.91M-55.48M-112.89M-118M
      Investing 3.88M-738k-1.42M105.77M-28.61M
      Financing 67.97M109.22M41.31M124.74M26.63M

      Stats and Ratios

      Market Cap 79.65M
      Price to Earnings Ratio -0.56
      Price to Sales Ratio 2.54
      Price to Cash Ratio 0.65
      Price to Book Ratio 4.69
      Dividend Yield -

      Share Statistics

      Shares Outstanding 54.93M
      Average Volume (1 week) 378.28k
      Average Volume (1 Month) 1.05M
      52 Week Change -84.90%
      52 Week High 11.26
      52 Week Low 1.10
      Spread (Intraday) 0.08 (5.52%)

      Company Info

      Company Name Marinus Pharmaceuticals Inc
      Address 3411 silverside road tatnall building
      wilmington, delaware 19810
      Website https://www.marinuspharma.com
      Industry pharmaceutical preparations (2834)